Choosing I Gel size for airway management
Not Applicable
- Conditions
- Health Condition 1: C50- Malignant neoplasm of breast
- Registration Number
- CTRI/2023/11/059423
- Lead Sponsor
- DR MALLIKA BALAKRISHNA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. ASA class 1, 2 and 3.
2. Patients who give consent to participate in study.
Exclusion Criteria
1. History of oropharyngeal or laryngeal surgery or pathology.
2. Patients with anticipated difficult airway.
3. Mouth opening smaller than 2.5 cm.
4. Body mass index greater than 35 kg/m2
5. Patients with increased risk of aspiration (hiatus hernia, gastro-oesophageal reflux, or full stomach)
6. Parturient women
7. Patients with difficult bag and mask ventilation.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The success rate of I-Gel insertion will be assessed at first ventilationTimepoint: Optimal placement of the I-Gel® will be confirmed by visible expansion of the chest wall and the appearance of square waveform on capnograph and SP02 95% within 1 minute after first ventilation.
- Secondary Outcome Measures
Name Time Method The incidence rate of complications of I gel insertion in two groups after extubation.Timepoint: After removal, the I-Gel® will be inspected immediately within 1 minute for visible blood as indicative of mucosal injury. Presence or absence of sore throat & hoarseness among patients will be asked for & recorded postoperatively for 24 hours.